Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatme...
Main Authors: | Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, Julia Lorenzo, Jordi Bruna, Victor J. Yuste, Ana Paula Candiota, Fernando Novio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/19/4960 |
Similar Items
-
Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy
by: Xiaoman Mao, et al.
Published: (2022-04-01) -
Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment
by: Xiaoman Mao, et al.
Published: (2022-01-01) -
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
by: Paula Alfonso-Triguero, et al.
Published: (2023-05-01) -
Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
by: Munazza Ahmed, et al.
Published: (2022-12-01) -
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
by: Mélodie Davy, et al.
Published: (2023-09-01)